Clinical Trial

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the efficacy of Prolia on lumbar spine BMD at 12 months.
Trial Details
NCT Number NCT06332014
Lead Sponsor Amgen
Conditions Osteoporosis
Enrollment 102 participants
Start Date 2024-08-06
Primary Completion 2027-01-23 (estimated)
Study Completion 2027-01-23 (estimated)
Updated on ClinicalTrials.gov 2026-02-12